company background image
MPAR

MLP Saglik Hizmetleri IBSE:MPARK Stock Report

Last Price

₺33.90

Market Cap

₺7.1b

7D

0.5%

1Y

50.8%

Updated

26 Jun, 2022

Data

Company Financials +
MPARK fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance5/6
Financial Health3/6
Dividends0/6

MPARK Stock Overview

MLP Saglik Hizmetleri A.S. provides healthcare service in Turkey.

MLP Saglik Hizmetleri Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for MLP Saglik Hizmetleri
Historical stock prices
Current Share Price₺33.90
52 Week High₺40.48
52 Week Low₺21.34
Beta0.61
1 Month Change-4.51%
3 Month Change11.08%
1 Year Change50.80%
3 Year Change193.00%
5 Year Changen/a
Change since IPO80.80%

Recent News & Updates

Shareholder Returns

MPARKTR HealthcareTR Market
7D0.5%1.9%1.3%
1Y50.8%-27.5%61.2%

Return vs Industry: MPARK exceeded the TR Healthcare industry which returned -27.5% over the past year.

Return vs Market: MPARK underperformed the TR Market which returned 61.2% over the past year.

Price Volatility

Is MPARK's price volatile compared to industry and market?
MPARK volatility
MPARK Average Weekly Movement5.3%
Healthcare Industry Average Movement5.3%
Market Average Movement5.9%
10% most volatile stocks in TR Market8.7%
10% least volatile stocks in TR Market4.1%

Stable Share Price: MPARK is not significantly more volatile than the rest of TR stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: MPARK's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199312,618Muharrem Ustahttps://www.mlpcare.com

MLP Saglik Hizmetleri A.S. provides healthcare service in Turkey. The company operates diagnosis and treatment units. It operates 30 hospitals with 6,000 beds in 15 cities under the Liv Hospital, VM Medical Park and Istinye University Hospital names.

MLP Saglik Hizmetleri Fundamentals Summary

How do MLP Saglik Hizmetleri's earnings and revenue compare to its market cap?
MPARK fundamental statistics
Market Cap₺7.05b
Earnings (TTM)₺394.81m
Revenue (TTM)₺6.77b

17.9x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MPARK income statement (TTM)
Revenue₺6.77b
Cost of Revenue₺4.91b
Gross Profit₺1.86b
Other Expenses₺1.47b
Earnings₺394.81m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.90
Gross Margin27.51%
Net Profit Margin5.83%
Debt/Equity Ratio169.5%

How did MPARK perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is MPARK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MPARK?

Other financial metrics that can be useful for relative valuation.

MPARK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.4x
Enterprise Value/EBITDA7.1x
PEG Ratio0.7x

Price to Earnings Ratio vs Peers

How does MPARK's PE Ratio compare to its peers?

MPARK PE Ratio vs Peers
The above table shows the PE ratio for MPARK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average31x

Price-To-Earnings vs Peers: MPARK is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (31x).


Price to Earnings Ratio vs Industry

How does MPARK's PE Ratio compare vs other companies in the Healthcare Industry?

Price-To-Earnings vs Industry: MPARK is expensive based on its Price-To-Earnings Ratio (17.9x) compared to the TR Healthcare industry average (17.9x)


Price to Earnings Ratio vs Fair Ratio

What is MPARK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MPARK PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.9x
Fair PE Ratio13x

Price-To-Earnings vs Fair Ratio: MPARK is expensive based on its Price-To-Earnings Ratio (17.9x) compared to the estimated Fair Price-To-Earnings Ratio (13x).


Share Price vs Fair Value

What is the Fair Price of MPARK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MPARK (TRY33.9) is trading below our estimate of fair value (TRY65.7)

Significantly Below Fair Value: MPARK is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: MPARK is good value based on its PEG Ratio (0.7x)


Discover undervalued companies

Future Growth

How is MLP Saglik Hizmetleri forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


27.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MPARK's forecast earnings growth (27.1% per year) is above the savings rate (9%).

Earnings vs Market: MPARK's earnings (27.1% per year) are forecast to grow faster than the TR market (16.1% per year).

High Growth Earnings: MPARK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MPARK's revenue (18.2% per year) is forecast to grow faster than the TR market (13.8% per year).

High Growth Revenue: MPARK's revenue (18.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MPARK's Return on Equity is forecast to be very high in 3 years time (53.7%).


Discover growth companies

Past Performance

How has MLP Saglik Hizmetleri performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


67.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MPARK has high quality earnings.

Growing Profit Margin: MPARK's current net profit margins (5.8%) are higher than last year (1.9%).


Past Earnings Growth Analysis

Earnings Trend: MPARK has become profitable over the past 5 years, growing earnings by 67.1% per year.

Accelerating Growth: MPARK's earnings growth over the past year (392.2%) exceeds its 5-year average (67.1% per year).

Earnings vs Industry: MPARK earnings growth over the past year (392.2%) exceeded the Healthcare industry 169.5%.


Return on Equity

High ROE: Whilst MPARK's Return on Equity (55.02%) is outstanding, this metric is skewed due to their high level of debt.


Discover strong past performing companies

Financial Health

How is MLP Saglik Hizmetleri's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: MPARK's short term assets (TRY3.1B) do not cover its short term liabilities (TRY3.7B).

Long Term Liabilities: MPARK's short term assets (TRY3.1B) exceed its long term liabilities (TRY1.7B).


Debt to Equity History and Analysis

Debt Level: MPARK's net debt to equity ratio (94.3%) is considered high.

Reducing Debt: MPARK's debt to equity ratio has reduced from 387.4% to 169.5% over the past 5 years.

Debt Coverage: MPARK's debt is well covered by operating cash flow (123.8%).

Interest Coverage: MPARK's interest payments on its debt are not well covered by EBIT (2.1x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is MLP Saglik Hizmetleri current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MPARK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MPARK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MPARK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MPARK's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MPARK has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

8.1yrs

Average board tenure


CEO

Muharrem Usta (56 yo)

no data

Tenure

Dr. Muharrem Usta has been Chairman of the Executive Board at Trabzonspor Sportif Yatirim ve Futbol Isletmeciligi Ticaret A.S since February 02, 2016 and served as its Director until 2018. Dr. Usta served...


Board Members

Experienced Board: MPARK's board of directors are considered experienced (8.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MLP Saglik Hizmetleri A.S.'s employee growth, exchange listings and data sources


Key Information

  • Name: MLP Saglik Hizmetleri A.S.
  • Ticker: MPARK
  • Exchange: IBSE
  • Founded: 1993
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: ₺7.052b
  • Shares outstanding: 208.04m
  • Website: https://www.mlpcare.com

Number of Employees


Location

  • MLP Saglik Hizmetleri A.S.
  • Flatofis
  • Haliç Otakçilar Cad. No: 78
  • Istanbul
  • 34050
  • Turkey

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/26 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.